Showing 1 - 3 results of 3 for search 'Neal J. Weinreb', query time: 0.03s Refine Results
  1. 1
    The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). <i>J. Clin. Med.</i> 2022, <i>11</i>, 5158

    The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction... by Pramod K. Mistry, Priya S. Kishnani, Manisha Balwani, Joel M. Charrow, Judy Hull, Neal J. Weinreb, Timothy M. Cox

    Published 2023-05-01
    Get full text
    Article
  2. 2
    Patients with Gaucher disease display systemic oxidative stress dependent on therapy status

    Patients with Gaucher disease display systemic oxidative stress dependent on therapy status by Reena V. Kartha, Marcia R. Terluk, Roland Brown, Abigail Travis, Usha R. Mishra, Kyle Rudser, Heather Lau, Jeanine R. Jarnes, James C. Cloyd, Neal J. Weinreb

    Published 2020-12-01
    Get full text
    Article
  3. 3
    Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)

    Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS) by Lina Titievsky, Tilman Schuster, Ronnie Wang, Muhammad Younus, Andrew Palladino, Kabir Quazi, Michael P. Wajnrajch, Betina Hernandez, Pamela S. Becker, Neal J. Weinreb, Christina Chambers, Roy Mansfield, Louise Taylor, Li-Jung Tseng, Paige Kaplan

    Published 2022-04-01
    Get full text
    Article

Search Tools: